3020-OL:HK:HK-X DBMSCIUSA (HKD)

COMMON STOCK | Other |

Last Closing

USD 1272.5

Change

+3.00 (+0.24)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

There is no Profile data available for 3020-OL.HK.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-29 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap
1863:HK China Longevity Group Company ..

N/A

USD 1.17B
8355:HK I-CONTROL

N/A

USD 0.39B
8343:HK HongGuang Lighting Holdings Co..

-0.01 (-1.92%)

USD 0.31B
0648:HK CHINA RENJ

N/A

USD 0.12B
0177-OL:HK JIANGSU EXPRESS

-0.23 (-2.34%)

N/A
0240-OL:HK BUILD KING HOLD

N/A

N/A
0243-OL:HK QPL INT'L

-0.01 (-3.92%)

N/A
0182-OL:HK CHINA WINDPOWER

-0.01 (-1.05%)

N/A
0259-OL:HK YEEBO (INT'L H)

+0.01 (+0.63%)

N/A
0187-OL:HK JINGCHENG MAC

+0.09 (+2.19%)

N/A

ETFs Containing 3020-OL:HK

DXZ:CA Dynamic Active U.S. Mid-C.. 11.35 % 0.87 %

+0.10 (+0.73%)

CAD 0.04B
IHF iShares U.S. Healthcare P.. 10.22 % 0.43 %

+0.23 (+0.73%)

N/A
TETF 6.19 % 0.64 %

N/A

N/A
BOUT Innovator ETFs Trust - In.. 5.99 % 0.80 %

+0.37 (+0.73%)

USD 0.01B
FHI:CA CI Health Care Giants Cov.. 5.16 % 0.75 %

+0.15 (+0.73%)

CAD 0.10B
FHI-B:CA CI Health Care Giants Cov.. 5.16 % 0.00 %

+0.07 (+0.73%)

CAD 0.05B
MID American Century Mid Cap .. 4.56 % 0.00 %

+0.47 (+0.73%)

USD 0.07B
IAI iShares U.S. Broker-Deale.. 4.54 % 0.42 %

+1.65 (+0.73%)

N/A
LCG Sterling Capital Focus Eq.. 4.46 % 0.00 %

+0.28 (+0.73%)

USD 0.03B
VSMV VictoryShares US Multi-Fa.. 3.37 % 0.35 %

+0.26 (+0.73%)

USD 0.11B
CBUF:XETRA iShares MSCI World Health.. 3.37 % 0.00 %

+0.05 (+0.73%)

N/A
CBLS Elevation Series Trust 3.19 % 0.00 %

-0.03 (0.73%)

USD 0.04B
CBSE Elevation Series Trust 2.98 % 0.00 %

-0.05 (0.73%)

USD 0.02B
HDIV 2.83 % 0.00 %

N/A

N/A
FXH First Trust Health Care A.. 2.31 % 0.63 %

+0.96 (+0.73%)

USD 0.89B
TDOC:CA TD Global Healthcare Lead.. 2.25 % 0.00 %

+0.13 (+0.73%)

CAD 0.08B
XHS SPDR® S&P Health Care Se.. 2.17 % 0.35 %

+0.69 (+0.73%)

USD 0.09B
FLXG:LSE Franklin LibertyQ Global .. 1.87 % 0.00 %

N/A

N/A
FRGE:LSE Franklin LibertyQ Global .. 1.87 % 0.00 %

N/A

USD 0.02B
KCE SPDR® S&P Capital Market.. 1.80 % 0.35 %

+1.04 (+0.73%)

N/A
DSTL Distillate US Fundamental.. 1.76 % 0.00 %

+0.17 (+0.73%)

USD 1.79B
RYH 1.72 % 0.40 %

N/A

N/A
HONR 1.20 % 0.65 %

N/A

N/A
CVY Invesco Zacks Multi-Asset.. 1.18 % 0.65 %

+0.10 (+0.73%)

USD 0.10B
SMD 0.45 % 0.10 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

-0.01 (0.73%)

USD 0.08B
JKH iShares Morningstar Mid-C.. 0.00 % 0.30 %

N/A

N/A
RYF 0.00 % 0.40 %

N/A

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

+0.23 (+0.73%)

N/A
WBIF WBI BullBear Value 3000 E.. 0.00 % 1.05 %

+0.12 (+0.73%)

N/A
XXM:CA 0.00 % 0.68 %

N/A

N/A
FSWD:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

+4.00 (+0.73%)

N/A
IFSW:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

+0.09 (+0.73%)

N/A
IBCZ:F iShares IV Public Limited.. 0.00 % 0.00 %

+0.13 (+0.73%)

N/A
IS07:F iShares IV Public Limited.. 0.00 % 0.00 %

+0.07 (+0.73%)

N/A
IS07:XETRA iShares Edge MSCI World M.. 0.00 % 0.00 %

+0.01 (+0.73%)

N/A
IMCG iShares Morningstar Mid-C.. 0.00 % 0.00 %

+0.48 (+0.73%)

N/A

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -6.36% 44% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.36% 43% F 42% F
Trailing 12 Months  
Capital Gain 8.53% 59% D- 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.53% 58% F 60% D-
Trailing 5 Years  
Capital Gain 104.91% 83% B 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 104.91% 83% B 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 15.54% 78% C+ 75% C
Dividend Return 15.54% 76% C+ 73% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 18.57% 79% B- 79% B-
Risk Adjusted Return 83.68% 95% A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:

There is nothing we particularly dislike